[1]. Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018. 68(6): p. 394-424.
[2]. Siegel, R.L., K.D. Miller and A. Jemal, Cancer statistics, 2019. CA Cancer J Clin, 2019. 69(1): p. 7-34.
[3]. Sun, S., et al., Development and validation of an immune-related prognostic signature in lung adenocarcinoma. Cancer Med, 2020. 9(16): p. 5960-5975.
[4]. Choi, B.H., et al., WWP2 is required for normal cell cycle progression. Genes Cancer, 2015. 6(9-10): p. 371-7.
[5]. Wang, Y., et al., HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance. J Cell Sci, 2020. 133(7).
[6]. Shao, G., et al., The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells. Mol Cancer, 2018. 17(1): p. 24.
[7]. Qu, M.H., et al., miR-93 promotes TGF-beta-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumour Biol, 2016. 37(4): p. 5645-51.
[8]. Yang, S., et al., Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival. Int J Cancer, 2020. 147(2): p. 392-403.
[9]. Yu, J.J., et al., TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target. Nat Commun, 2020. 11(1): p. 3660.
[10]. Wang, L., et al., ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis. Carcinogenesis, 2020. 41(5): p. 711-721.
[11]. Li, H., et al., Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKIgamma. Oncogene, 2017. 36(41): p. 5668-5680.
[12]. Chae, D.K., et al., MiR-195 and miR-497 suppress tumorigenesis in lung cancer by inhibiting SMURF2-induced TGF-beta receptor I ubiquitination. Mol Oncol, 2019. 13(12): p. 2663-2678.
[13]. Lu, C., et al., E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4. Biochem Cell Biol, 2021: p. 1-7.
[14]. Li, P.F. and Q.G. Zhang, Inhibition of ITCH Suppresses Proliferation and Induces Apoptosis of Lung Cancer Cells. Cell Physiol Biochem, 2018. 48(4): p. 1703-1709.
[15]. Janne, P.A., J.A. Engelman and B.E. Johnson, Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol, 2005. 23(14): p. 3227-34.
[16]. Fu, H., et al., Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer. Cancer Commun (Lond), 2018. 38(1): p. 18.
[17]. Liu, R., et al., Characteristics of TGFBR1-EGFR-CTNNB1-CDH1 Signaling Axis in Wnt-Regulated Invasion and Migration in Lung Cancer. Cell Transplant, 2020. 29: p. 963689720969167.
[18]. Shah, K.N., et al., Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med, 2019. 25(1): p. 111-118.
[19]. Murugan, A.K., mTOR: Role in cancer, metastasis and drug resistance. Semin Cancer Biol, 2019. 59: p. 92-111.
[20]. Avruch, J., et al., Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene, 2006. 25(48): p. 6361-72.
[21]. Dibble, C.C. and L.C. Cantley, Regulation of mTORC1 by PI3K signaling. Trends Cell Biol, 2015. 25(9): p. 545-55.
[22]. Deng, L., et al., Ubiquitination of Rheb governs growth factor-induced mTORC1 activation. Cell Res, 2019. 29(2): p. 136-150.
[23]. Hong, S.Y., et al., Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma. Cancer Res, 2018. 78(17): p. 4984-4996.
[24]. Zhang, J., et al., Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosis. Life Sci, 2020. 257: p. 118131.
[25]. Li, G.Y., et al., Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-beta-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Theranostics, 2018. 8(10): p. 2846-2861.
[26]. Zhang, D., et al., FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC. Onco Targets Ther, 2019. 12: p. 9809-9816.
[27]. Yuan, Y., et al., Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients. Front Immunol, 2021. 12: p. 659444.
[28]. Li, G., et al., Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer. Int J Cancer, 2019. 145(12): p. 3285-3298.
[29]. Morita, M., et al., mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle, 2015. 14(4): p. 473-80.
[30]. Mari, S., et al., Structural and functional framework for the autoinhibition of Nedd4-family ubiquitin ligases. Structure, 2014. 22(11): p. 1639-49.
[31]. Chen, C. and L.E. Matesic, The Nedd4-like family of E3 ubiquitin ligases and cancer. Cancer Metastasis Rev, 2007. 26(3-4): p. 587-604.
[32]. Nalepa, G., M. Rolfe and J.W. Harper, Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov, 2006. 5(7): p. 596-613.
[33]. Yang, S., et al., Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival. Int J Cancer, 2020. 147(2): p. 392-403.
[34]. Broix, L., et al., Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia. Nat Genet, 2016. 48(11): p. 1349-1358.
[35]. Yu, J.S. and W. Cui, Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination. Development, 2016. 143(17): p. 3050-60.
[36]. Wang, X., et al., Decreased expression of NEDD4L contributes to NSCLC progression and metastasis. Biochem Biophys Res Commun, 2019. 513(2): p. 398-404.
[37]. Uribe, M.L., I. Marrocco and Y. Yarden, EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. Cancers (Basel), 2021. 13(11).
[38]. Kong, D., et al., DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells. Circulation, 2020. 141(8): p. 655-666.
[39]. Arthur-Farraj, P.J., et al., Changes in the Coding and Non-coding Transcriptome and DNA Methylome that Define the Schwann Cell Repair Phenotype after Nerve Injury. Cell Rep, 2017. 20(11): p. 2719-2734.
[40]. Fu, J., D. Akhmedov and R. Berdeaux, The short isoform of the ubiquitin ligase NEDD4L is a CREB target gene in hepatocytes. PLoS One, 2013. 8(10): p. e78522.
[41]. Ramaiah, M.J. and K.R. Kumar, mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme. Mol Biol Rep, 2021. 48(5): p. 4813-4835.
[42]. Cui, J., H.M. Shen and L. Lim, The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets. Pharmaceuticals (Basel), 2020. 13(12).